Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research suggests. The infection is called human monocytic ehrlichiosis (HME), and is one of the most prevalent and potentially life-threatening tick-borne […]
The post Tick-Borne Infection Immune to Most Antibiotics May Be Blocked Using Special ‘Nanobodies’ appeared first on Good News Network.
